The trademark application was filed by Biomea Fusion, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 13, 2021, and it was registered by office on December 21, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Chemotherapeutics
Adjuvants for medical purposes
Anti-cancer preparations
Anti-sarcoma preparations
Cellular function activating agents for medical purposes
Chemical preparations for pharmaceutical or medical purposes, namely, for cancer and metabolic diseases
Cytostatics for pharmaceutical purposes
Diagnostic preparations for medical purposes
Medical preparations for the treatment of cancer and metabolic diseases
Medicinal preparations for the treatment of infectious diseases and for use in oncology
Medicinal preparations for cancer and metabolic diseases
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue
Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Pharmaceutical preparations for treating chemical imbalances
Pharmaceutical preparations for use in chemotherapy
Pharmaceutical preparations for the prevention of cancer and metabolic diseases
Pharmaceutical preparations for the treatment of immune system related diseases and disorders
Pharmaceutical preparations for the treatment of cancer and metabolic diseases
Pharmaceutical preparations for the treatment and prevention of cancer and metabolic diseases
Pharmaceutical preparations for cancer and metabolic diseases
Pharmaceutical preparations, namely, elixirs for the treatment of cancer and metabolic diseases
Pharmaceutical products for the prevention and treatment of cancer
Pharmaceutical products for the treatment of cancer
Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer
Therapeutic pharmaceutical products for the treatment of cancer and metabolic diseases
Tumor suppressing agents
Medicinal infusions for treating cancer and metabolic diseases
Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents.
The mark was filed in class 42 with following description of goods:
Biotechnology research
Development of new technology for others in the field of cancer and metabolic diseases
Development of pharmaceutical preparations and medicines
Medical and scientific research in the field of cancer treatment and diagnosis
Pharmaceutical drug development services
Pharmaceutical products development
Pharmaceutical research and development
Providing information on the subject of scientific research in the field of biochemistry and biotechnology
Providing medical research and scientific research information in the field of oncology via the internet
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Providing medical and scientific research information in the fields of pharmaceuticals and genetics
Research and development in the pharmaceutical and biotechnology fields
Research and development of pharmaceuticals for the treatment of age-related diseases and cancer
Scientific research for medical purposes in the area of cancerous diseases
Scientific research for medical purposes in the field of cancer and metabolic diseases
Testing of pharmaceuticals
Medical research services
Pharmaceutical research services
Research and development of vaccines and medicines.
The mark was filed in class 44 with following description of goods:
Providing a web site with medical information
Providing a website with information in the field of the diagnosis and treatment of cancer and metabolic diseases
Providing medical testing services and information in the field of cancer research and disease classification.